Use of Core-Needle Biopsy for Image-Detected Abnormalities

This course provides physicians with an overview of the core-needle biopsy process to be better able to explain to patients what to expect and explain the available validated methods for this method of biopsy.

RETURN TO MAIN PAGE: Breast Cancer for the Non-Oncologist: Supporting Your Patients Through Diagnosis and Treatment   

Target Audience

Family Medicine Physicians, Ob/Gyns, Internal Medicine Physicians, Physician Assistants, Medical Students and Residents.

Learning Objectives

  • Review the options and the patient selection process. 
  • Consider available, validated methods for CNB: stereotactic, tomogram, ultrasound and MRI-guided. 
  • Review the importance of radiologic-pathologic concordance. 
  • Designate the appropriate follow-up and disposition of the patient based on radiology-pathology results. 
Additional information
  • Downs-Kelley, et al. “Clinical Implications of Margin Involvement by Pleomorphic Lobular Carcinoma in Situ.” Arch Pathol Lab Med ̶ Vol 135, June 2011
  • Portschy, et al. “Trends in Incidence and Management of Lobular Carcinoma in Situ: A Population-Based Analysis.” Annals of Surgical Oncology. 12 July 2013
  • Hussain, et. al. “Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast- A review.” EJSO 37 (2011) 279e289.
  • Murray, et. al. “Classic Lobular Carcinoma in Situ and Atypical Lobular Hyperplasia at Percutaneous Breast Core Biopsy.” Cancer. 1 March 2013
  • Page, et. al. “Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk; a retrospective cohort study.” THE LANCET • Vol 361 • January 11, 2013
Course Summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 General certificate of attendance
Course opens: 
Course expires: 

Maria Pilar Martinez, M.D. 
Baptist Health Breast Center
Miami Cancer Institute

Maria Pilar Martinez, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in her presentations or discussions.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose. 

Disclosure Policy and Disclaimer 

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 General certificate of attendance
Please login or register for a Baptist Health CME account to take this course.